<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-244 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-244</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-244</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-12.html">extraction-schema-12</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of mechanisms, clinical findings, and evidence explaining the association between thymomas and autoimmunity.</div>
                <p><strong>Paper ID:</strong> paper-63654559dc7b3b9611b65f73139f8fccaf98124e</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/63654559dc7b3b9611b65f73139f8fccaf98124e" target="_blank">Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis</a></p>
                <p><strong>Paper Venue:</strong> Frontiers in Immunology</p>
                <p><strong>Paper TL;DR:</strong> Overall, this review underscores the integral role of thymic tissue homeostasis in the prevention of autoimmune diseases, discussing insights into potential therapeutic strategies and examining putative avenues for future research on developing thymic-based therapies in treating and preventing autoimmune conditions.</p>
                <p><strong>Paper Abstract:</strong> The intricate balance of immune reactions towards invading pathogens and immune tolerance towards self is pivotal in preventing autoimmune diseases, with the thymus playing a central role in establishing and maintaining this equilibrium. The induction of central immune tolerance in the thymus involves the elimination of self-reactive T cells, a mechanism essential for averting autoimmunity. Disruption of the thymic T cell selection mechanisms can lead to the development of autoimmune diseases. In the dynamic microenvironment of the thymus, T cell migration and interactions with thymic stromal cells are critical for the selection processes that ensure self-tolerance. Thymic epithelial cells are particularly significant in this context, presenting self-antigens and inducing the negative selection of autoreactive T cells. Further, the synergistic roles of thymic fibroblasts, B cells, and dendritic cells in antigen presentation, selection and the development of regulatory T cells are pivotal in maintaining immune responses tightly regulated. This review article collates these insights, offering a comprehensive examination of the multifaceted role of thymic tissue homeostasis in the establishment of immune tolerance and its implications in the prevention of autoimmune diseases. Additionally, the developmental pathways of the thymus are explored, highlighting how genetic aberrations can disrupt thymic architecture and function, leading to autoimmune conditions. The impact of infections on immune tolerance is another critical area, with pathogens potentially triggering autoimmunity by altering thymic homeostasis. Overall, this review underscores the integral role of thymic tissue homeostasis in the prevention of autoimmune diseases, discussing insights into potential therapeutic strategies and examining putative avenues for future research on developing thymic-based therapies in treating and preventing autoimmune conditions.</p>
                <p><strong>Cost:</strong> 0.016</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e244.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e244.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of mechanisms, clinical findings, and evidence explaining the association between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Myasthenia gravis (MG)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Myasthenia gravis</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>An autoantibody-mediated neuromuscular disease frequently reported in association with thymic pathology, particularly thymic hyperplasia and thymomas; clinically characterized by fluctuating muscle weakness due to antibodies against neuromuscular junction proteins.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Myasthenia gravis</td>
                        </tr>
                        <tr>
                            <td><strong>prevalence_in_thymoma_patients</strong></td>
                            <td>In one cited study of 116 thymomas, 34 patients developed myasthenia gravis (34/116; ~29.3%)</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Thymoma-associated disruption of intrathymic tolerance via reduced MHCII and AIRE expression in thymic epithelial/tumor cells leading to defective negative selection, plus intrathymic germinal center formation and local B cell maturation producing pathogenic autoantibodies; ectopic/aberrant expression of neuromuscular (neuronal) antigens by medullary TEC-like cells within thymomas may drive antigen-specific autoimmunity.</td>
                        </tr>
                        <tr>
                            <td><strong>supporting_evidence</strong></td>
                            <td>Histological and molecular analyses of thymomas show reduced MHCII and AIRE in epithelial cells (cited); a bulk- and single-cell RNA-seq study of 116 thymomas (34 MG cases) described germinal center formation, B cell maturation, and ectopic neuromuscular gene expression by KRT6+ GABRA5+ neuromuscular mTECs in MG-associated thymomas; prior reports show thymic hyperplasia with B cell follicles and increased CXCL13/BAFF in MG thymus, supporting local B cell recruitment and GC formation.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td>A report cited (Strobel et al., ref.224) found AIRE deficiency in thymomas but concluded this alone is insufficient to elicit APS-1–type systemic autoimmunity, indicating that AIRE loss may not fully explain thymoma-associated autoimmunity.</td>
                        </tr>
                        <tr>
                            <td><strong>patient_demographics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>interventions_modulating_autoimmunity</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>Thymomas are strongly associated with MG; thymoma epithelial cells frequently show reduced MHCII and AIRE expression and some MG-associated thymomas develop ectopic neuromuscular antigen expression and germinal centers, providing plausible intrathymic mechanisms for autoantibody generation.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations</strong></td>
                            <td>Evidence is largely correlative/observational and from case series and transcriptomic analyses; causality is not fully established and AIRE deficiency alone does not explain all cases; patient-level demographic and longitudinal treatment/outcome data are not provided in the cited summary.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis', 'publication_date_yy_mm': '2024-03'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e244.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e244.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of mechanisms, clinical findings, and evidence explaining the association between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Reduced AIRE / MHCII in thymomas</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Reduced expression of Autoimmune Regulator (AIRE) and MHC class II in thymoma epithelial cells</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Thymoma epithelial cells frequently exhibit decreased AIRE and MHC class II levels, which is proposed to impair promiscuous self-antigen expression and antigen presentation required for negative selection of autoreactive T cells.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Autoimmunity generally (examples include myasthenia gravis, pure red cell aplasia)</td>
                        </tr>
                        <tr>
                            <td><strong>prevalence_in_thymoma_patients</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Loss/reduction of AIRE and reduced MHCII expression in thymoma epithelial cells → impaired thymic expression/presentation of tissue-restricted antigens and deficient negative selection → survival/egress of autoreactive T cells that can mediate autoimmunity.</td>
                        </tr>
                        <tr>
                            <td><strong>supporting_evidence</strong></td>
                            <td>Immunohistochemical/molecular findings reported in the literature (cited) show reduced AIRE and MHCII in thymoma epithelial cells; mechanistic inference is based on established AIRE role in TRA expression and negative selection and on associations between AIRE deficiency and autoimmune syndromes (APS1) in other contexts.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td>Cited work (ref.224) indicates AIRE deficiency in thymomas is insufficient by itself to induce APS1-like disease, implying additional factors are required for clinical autoimmunity in thymoma patients.</td>
                        </tr>
                        <tr>
                            <td><strong>patient_demographics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>interventions_modulating_autoimmunity</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>Reduced AIRE and MHCII in thymoma epithelial cells is a credible mechanism for defective central tolerance, but AIRE loss alone may not fully account for thymoma-associated autoimmunity.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations</strong></td>
                            <td>Most evidence is associative; direct demonstration that reduced AIRE/MHCII in thymoma causes specific autoimmunity in humans is lacking and experimental (causal) models are limited.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis', 'publication_date_yy_mm': '2024-03'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e244.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e244.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of mechanisms, clinical findings, and evidence explaining the association between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Thymic germinal centers / B cell maturation</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Ectopic germinal center formation and B cell maturation within thymomas / thymic hyperplasia</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Thymomas and thymic lymphoid hyperplasia can harbor B cell follicles with germinal centers that support local B cell maturation and plasma cell development, providing a local source of autoantibodies.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Myasthenia gravis (and other thymoma-associated autoantibody syndromes)</td>
                        </tr>
                        <tr>
                            <td><strong>prevalence_in_thymoma_patients</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Formation of intrathymic germinal centers → local affinity maturation of B cells and plasma cell generation → production of pathogenic autoantibodies (paraneoplastic autoimmunity).</td>
                        </tr>
                        <tr>
                            <td><strong>supporting_evidence</strong></td>
                            <td>Pathology descriptions in MG-associated thymomas and thymic hyperplasia frequently note B cell follicles and germinal centers; studies cited report increased chemotactic signals (CXCL13) and higher BAFF release by TECs that promote B cell recruitment and maturation in MG thymus; transcriptomic analyses of MG-associated thymomas show features consistent with B cell maturation and GC formation.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_demographics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>interventions_modulating_autoimmunity</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>Intrathymic GC formation and enhanced B cell maturation in thymomas provide a plausible local source of autoantibodies implicated in diseases like MG.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations</strong></td>
                            <td>Observations are descriptive; functional proof linking specific intrathymic GC output to circulating pathogenic autoantibodies in patients is suggestive but not definitively proven in the cited review.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis', 'publication_date_yy_mm': '2024-03'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e244.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e244.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of mechanisms, clinical findings, and evidence explaining the association between thymomas and autoimmunity.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Tumor autoimmunization / antibody production</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Spontaneous autoantibody production by thymoma cells (tumor autoimmunization)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Thymoma cells themselves have been reported to produce autoantibodies (or to support their production), suggesting a paraneoplastic autoimmunization mechanism independent of classical central tolerance failure.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>autoimmune_disease_name</strong></td>
                            <td>Myasthenia gravis and other paraneoplastic autoantibody syndromes</td>
                        </tr>
                        <tr>
                            <td><strong>prevalence_in_thymoma_patients</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Thymoma tumor cells or tumor-associated microenvironment directly generate or induce production of autoantibodies (paraneoplastic phenomenon), possibly via ectopic expression/secretion of cytokines and antigens and by supporting B cell/plasma cell differentiation.</td>
                        </tr>
                        <tr>
                            <td><strong>supporting_evidence</strong></td>
                            <td>Cited reports describe spontaneous production of anti-IFN-α and anti-IL-12 autoantibodies by thymoma cells from MG patients (ref.228), and case series link thymomas with paraneoplastic autoimmune manifestations; transcriptomic/histologic evidence of tumor-associated antigen expression and GC-like structures support the concept.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>patient_demographics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>interventions_modulating_autoimmunity</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>key_findings</strong></td>
                            <td>Beyond defective negative selection, thymomas may directly contribute to autoimmunity by fostering intratumoral autoantibody production or by providing a niche that drives B cell autoimmunization.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations</strong></td>
                            <td>Reports are limited/observational and mechanistic pathways (which tumor cells vs which signals) are incompletely defined; it's unclear how frequently tumor autoantibody production is the dominant mechanism versus impaired T cell selection.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis', 'publication_date_yy_mm': '2024-03'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Autoimmune disease in patients with advanced thymic epithelial tumors <em>(Rating: 2)</em></li>
                <li>Thymoma associated with autoimmune diseases: 85 cases and literature review <em>(Rating: 2)</em></li>
                <li>Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma <em>(Rating: 2)</em></li>
                <li>Deficiency of the autoimmune regulator aire in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (Aps-1) <em>(Rating: 2)</em></li>
                <li>Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers <em>(Rating: 2)</em></li>
                <li>Spontaneous production of anti-ifs-alpha and anti-il-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor <em>(Rating: 2)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>